DUSA Pharmaceuticals
For Physicians  |  For Investors  |  For Pharmacists  |  Contact Us
HomeProductsAbout DUSANews/Events
Press Releases
  • November 4, 2008
  • November 3, 2008
  • November 3, 2008
  • October 27, 2008
  • October 22, 2008
  • October 22, 2008
  • August 19, 2008
  • August 12, 2008
  • August 14, 2007
  • August 8, 2008
  • August 8, 2008
  • August 4, 2008
  • July 31, 2008
  • July 18, 2008
  • June 19, 2008
  • May 16, 2008
  • May 7, 2008
  • May 7, 2008
  • May 2, 2008
  • May 1, 2008
  • March 31, 2008
  • April 21, 2008
  • March 6, 2008
  • March 4, 2008 Fourth Quarter and Full Year 2007 Conference Call
  • March 4, 2008
  • February 28, 2008
  • February 20, 2008
  • February 13, 2008
  • February 6, 2008
  • 2007 Press Releases
Press Releases
Home » News/Events » Press Releases

Press Releases

November 3, 2008
DUSA Pharmaceuticals Reports Third Quarter 2008 Corporate Highlights and Financial Results

November 4, 2008
DUSA Pharmaceuticals to present at the Rodman & Renshaw 10th Annual Healthcare Conference

November 3, 2008
Third Quarter 2008 Corporate Highlights and Financial Results Conference Call

October 27, 2008
DUSA Pharmaceuticals, Inc. Announces Third Quarter Financial Results and Corporate Highlights Conference Call

October 22, 2008
Recorded Conference Call - DUSA Announces Results for Phase IIB Acne Trial of Levulan® Photodynamic Therapy for Moderate to Severe Acne

October 22, 2008
DUSA Announces Results for Phase IIB Trial of Levulan® Photodynamic Therapy for Moderate to Severe Acne

August 19, 2008
DUSA Investor Presentation at the Fourth Annual Noble Financial Equity Conference

August 14, 2007
DUSA Announces Patent Licensing Agreement

August 12, 2008
DUSA Pharmaceuticals to Present at the Noble Financial Equity Conference

August 8, 2008
Second Quarter 2008 Corporate Highlights and Financial Results Conference Call

< Previous 123 Next >

 

Customer Service | Reimbursement/Insurance Coverage
Careers | Legal Notice/Privacy Policy
© 2009, DUSA Pharmaceuticals, Inc.
All Rights Reserved.